Literature DB >> 11815283

HIV-1 VPR modulates cell cycle G2/M transition through an alternative cellular mechanism other than the classic mitotic checkpoints.

Robert T Elder1, Zsigmond Benko, Yuqi Zhao.   

Abstract

HIV-1 Vpr induces cell cycle G2/M arrest in both human and fission yeast cells, suggesting a highly conserved activity of this viral protein. In this review, we summarize the current understanding of Vpr-induced G2 arrest based on studies from both mammalian cells and the fission yeast (Schizosaccharomyces pombe) model system. Fission yeast has proven to be an excellent model system to investigate cell cycle G2/M control of eukaryotic cells. Similarly, fission yeast has also been instrumental in defining the molecular mechanism underlying the G2 arrest induced by Vpr. We have compared the classic DNA-damage and DNA-replication checkpoint controls of the cell cycle G2/M transition to the G2 arrest conferred by Vpr. Based on the current findings, we hypothesize that Vpr induces cell cycle G2 arrest through an alternative novel cellular pathway(s) rather than through the classic mitotic checkpoint controls. A number of cellular proteins which may be involved in this new cellular pathway(s) have been identified and are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11815283     DOI: 10.2741/elder

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  20 in total

1.  Recent Insights into HIV Accessory Proteins.

Authors:  Jenny L. Anderson; Thomas J. Hope
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

2.  Human immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145.

Authors:  Yasuhiko Terada; Yuko Yasuda
Journal:  Mol Cell Biol       Date:  2006-08-21       Impact factor: 4.272

3.  The dose-dependent H2O2 stress response promotes increased survival for Schizosaccharomyces pombe cells expressing HIV-1 Vpr.

Authors:  J Antal; M Pesti
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

4.  Borna disease virus nucleoprotein interacts with the CDC2-cyclin B1 complex.

Authors:  Oliver Planz; Stephan Pleschka; Katja Oesterle; Friederike Berberich-Siebelt; Christina Ehrhardt; Lothar Stitz; Stephan Ludwig
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma.

Authors:  Richard Y Zhao; Dong Liang; Ge Li; Christopher W Larrimore; Bernard L Mirkin
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

6.  Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R.

Authors:  Ge Li; Hyeon U Park; Dong Liang; Richard Y Zhao
Journal:  Retrovirology       Date:  2010-07-07       Impact factor: 4.602

Review 7.  HIV-1 viral protein R (Vpr) and its interactions with host cell.

Authors:  Ge Li; Michael Bukrinsky; Richard Y Zhao
Journal:  Curr HIV Res       Date:  2009-03       Impact factor: 1.581

8.  Mitosis-specific anchoring of gamma tubulin complexes by pericentrin controls spindle organization and mitotic entry.

Authors:  Wendy C Zimmerman; James Sillibourne; Jack Rosa; Stephen J Doxsey
Journal:  Mol Biol Cell       Date:  2004-05-14       Impact factor: 4.138

9.  Anti-Vpr activity of a yeast chaperone protein.

Authors:  Zsigmond Benko; Dong Liang; Emmanuel Agbottah; Jason Hou; Karen Chiu; Min Yu; Scott Innis; Patrick Reed; William Kabat; Robert T Elder; Paola Di Marzio; Lorena Taricani; Lee Ratner; Paul G Young; Michael Bukrinsky; Richard Yuqi Zhao
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Impact on genetic networks in human macrophages by a CCR5 strain of human immunodeficiency virus type 1.

Authors:  Carter R Coberley; James J Kohler; Joseph N Brown; Joseph T Oshier; Henry V Baker; Michael P Popp; John W Sleasman; Maureen M Goodenow
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.